Matteo Marzaroli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The authors reply.

The authors reply.

Journal: Critical care medicine

Published: November 20, 2025

A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis.

A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis.

Journal: Critical care medicine

Published: May 29, 2025

Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol.

Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol.

Journal: Contemporary clinical trials

Published: December 28, 2024

Optimizing meropenem infusion: the importance of concentration and stability.

Optimizing meropenem infusion: the importance of concentration and stability.

Journal: Intensive care medicine

Published: October 22, 2024

Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial.

Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial.

Journal: British journal of anaesthesia

Published: August 20, 2024

Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial.

Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial.

Journal: JAMA

Published: June 16, 2023

High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial.

High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial.

Journal: Contemporary clinical trials

Published: March 31, 2023

Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design.

Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design.

Journal: Contemporary clinical trials

Published: November 09, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026